AJP - Heart Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 280: H384-H391, 2001;
0363-6135/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (56)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, G.-Y.
Right arrow Articles by Wong, T.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, G.-Y.
Right arrow Articles by Wong, T.-M.
Vol. 280, Issue 1, H384-H391, January 2001

kappa - but not delta -opioid receptors mediate effects of ischemic preconditioning on both infarct and arrhythmia in rats

Guan-Ying Wang, Song Wu, Jian-Ming Pei, Xiao-Chun Yu, and Tak-Ming Wong

Department of Physiology and Institute of Cardiovascular Sciences and Medicine, Faculty of Medicine, University of Hong Kong, Hong Kong

Two series of experiments were performed in the isolated perfused rat heart to determine the role of kappa - and delta -opioid receptors (OR) in cardioprotection of ischemic preconditioning (IP). In the first series of experiments, it was found that IP with two cycles of 5-min regional ischemia followed by 5-min reperfusion each reduced infarct size induced by 30-min ischemia, and the ameliorating effect of IP on infarct was attenuated with blockade of either 5 × 10-6 mol/l nor-binaltorphimine (nor-BNI), a selective kappa -OR antagonist, or 5 × 10-6 mol/l naltrindole (NTD), a selective delta -OR antagonist. The second series showed that U50,488H, a selective kappa -OR agonist, or D-Ala2-D-leu5-enkephalin (DADLE), a selective delta -OR agonist, dose dependently reduced the infarct size induced by ischemia, which mimicked the effects of IP. The effect of 10-5 mol/l U50,488H on infarct was significantly attenuated by blockade of protein kinase C (PKC) with specific PKC inhibitors, 5 × 10-6 mol/l chelerythrine or 8 × 10-7 mol/l calphostin C, as well as by blockade of ATP-sensitive K+ (KATP) channels with blockers of the channel, 10-5 mol/l glibenclamide or 10-4 mol/l 5-hydroxydecanoate. IP also reduced arrhythmia induced by ischemia. Nor-BNI, but not NTD, attenuated, while U50,488H, but not DADLE, mimicked the antiarrhythmic action of IP. In conclusion, the present study has provided first evidence that kappa -OR mediates the ameliorating effects of IP on infarct and arrhythmia induced by ischemia, whereas delta -OR mediates the effects only on infarct. Both PKC and KATP channels mediate the effect of activation of kappa -OR on infarct.

opioid receptor; protein kinase C; ATP-sensitive potassium channel


This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
J. Xi, W. Tian, L. Zhang, Y. Jin, and Z. Xu
Morphine prevents the mitochondrial permeability transition pore opening through NO/cGMP/PKG/Zn2+/GSK-3{beta} signal pathway in cardiomyocytes
Am J Physiol Heart Circ Physiol, February 1, 2010; 298(2): H601 - H607.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
S. Tsang, S. S. C. Wong, S. Wu, G. M. Kravtsov, and T.-M. Wong
Testosterone-augmented contractile responses to {alpha}1- and {beta}1-adrenoceptor stimulation are associated with increased activities of RyR, SERCA, and NCX in the heart
Am J Physiol Cell Physiol, April 1, 2009; 296(4): C766 - C782.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. M. Shioura, D. L. Geenen, and P. H. Goldspink
Sex-related changes in cardiac function following myocardial infarction in mice
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2008; 295(2): R528 - R534.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
A. J. Zatta, H. Kin, D. Yoshishige, R. Jiang, N. Wang, J. G. Reeves, J. Mykytenko, R. A. Guyton, Z.-Q. Zhao, J. L. Caffrey, et al.
Evidence that cardioprotection by postconditioning involves preservation of myocardial opioid content and selective opioid receptor activation
Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1444 - H1451.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
C. K. Yu, Y.-H. Li, G. T. C. Wong, T. M. Wong, and M. G. Irwin
Remifentanil preconditioning confers delayed cardioprotection in the rat
Br. J. Anaesth., November 1, 2007; 99(5): 632 - 638.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
K. M. Shioura, D. L. Geenen, and P. H. Goldspink
Assessment of cardiac function with the pressure-volume conductance system following myocardial infarction in mice
Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2870 - H2877.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
J. Vinten-Johansen, Z.-Q. Zhao, R. Jiang, A. J. Zatta, and G. P. Dobson
Preconditioning and postconditioning: innate cardioprotection from ischemia-reperfusion injury
J Appl Physiol, October 1, 2007; 103(4): 1441 - 1448.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
E. R. Gross and G. J. Gross
Ligand triggers of classical preconditioning and postconditioning
Cardiovasc Res, May 1, 2006; 70(2): 212 - 221.
[Abstract] [Full Text] [PDF]

Home page
 Evid Based Complement Alternat MedHome page
C. Ventura
CAM and Cell Fate Targeting: Molecular and Energetic Insights into Cell Growth and Differentiation
Evid. Based Complement. Altern. Med., September 1, 2005; 2(3): 277 - 283.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Cao, L. Liu, and D. M. Van Winkle
Met5-enkephalin-induced cardioprotection occurs via transactivation of EGFR and activation of PI3K
Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1955 - H1964.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
S. Barrere-Lemaire, N. Combes, C. Sportouch-Dukhan, S. Richard, J. Nargeot, and C. Piot
Morphine mimics the antiapoptotic effect of preconditioning via an Ins(1,4,5)P3 signaling pathway in rat ventricular myocytes
Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H83 - H88.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
S. Pepe, O. W.V van den Brink, E. G Lakatta, and R.-P. Xiao
Cross-talk of opioid peptide receptor and {beta}-adrenergic receptor signalling in the heart
Cardiovasc Res, August 15, 2004; 63(3): 414 - 422.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
R. Schulz and G. Heusch
Connexin 43 and ischemic preconditioning
Cardiovasc Res, May 1, 2004; 62(2): 335 - 344.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
M. Zaugg, E. Lucchinetti, M. Uecker, T. Pasch, and M. C. Schaub
Anaesthetics and cardiac preconditioning. Part I. Signalling and cytoprotective mechanisms
Br. J. Anaesth., October 1, 2003; 91(4): 551 - 565.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Cao, L. Liu, and D. M. Van Winkle
Activation of {delta}- and {kappa}-opioid receptors by opioid peptides protects cardiomyocytes via KATP channels
Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1032 - H1039.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
W. G. Pyle, Y. Chen, and P. A. Hofmann
Cardioprotection through a PKC-dependent decrease in myofilament ATPase
Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1220 - H1228.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
J. P Headrick, L. Willems, K. J Ashton, K. Holmgren, J. Peart, and G P. Matherne
Ischaemic tolerance in aged mouse myocardium: the role of adenosine and effects of A1 adenosine receptor overexpression
J. Physiol., June 15, 2003; 549(3): 823 - 833.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
J. A. Coles Jr., D. C. Sigg, and P. A. Iaizzo
Role of kappa -opioid receptor activation in pharmacological preconditioning of swine
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2091 - H2099.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
J. Peart and J. P Headrick
Adenosine-mediated early preconditioning in mouse: protective signaling and concentration dependent effects
Cardiovasc Res, June 1, 2003; 58(3): 589 - 601.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
R. M Fryer, J. A Auchampach, and G. J Gross
Therapeutic receptor targets of ischemic preconditioning
Cardiovasc Res, August 15, 2002; 55(3): 520 - 525.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
D. C. Sigg, J. A. Coles Jr., P. R. Oeltgen, and P. A. Iaizzo
Role of delta -opioid receptor agonists on infarct size reduction in swine
Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H1953 - H1960.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
R. Schulz, M. V Cohen, M. Behrends, J. M Downey, and G. Heusch
Signal transduction of ischemic preconditioning
Cardiovasc Res, November 1, 2001; 52(2): 181 - 198.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online